Cargando…
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus
Introduction: Adjunctive therapy with polyclonal intravenous immunoglobins (IVIg) is currently used for preventing or managing infections and sepsis, especially in immunocompromised patients. The pathobiology of COVID-19 and the mechanisms of action of Ig led to the consideration of this adjunctive...
Autores principales: | Coloretti, Irene, Berlot, Giorgio, Busani, Stefano, De Rosa, Francesco Giuseppe, Donati, Abele, Forfori, Francesco, Grasselli, Giacomo, Mirabella, Lucia, Tascini, Carlo, Viale, Pierluigi, Girardis, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396919/ https://www.ncbi.nlm.nih.gov/pubmed/34441796 http://dx.doi.org/10.3390/jcm10163500 |
Ejemplares similares
-
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol
por: Busani, Stefano, et al.
Publicado: (2021) -
Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)
por: Biagioni, Emanuela, et al.
Publicado: (2021) -
Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.
por: Serafini, G, et al.
Publicado: (2012) -
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial
por: Busani, Stefano, et al.
Publicado: (2020) -
Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement
por: Cortegiani, Andrea, et al.
Publicado: (2023)